Get the latest Science News and Discoveries

Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder

None

Related news:

Bone marrow disorder nearly 10-times more common in those with venom allergy

A single dose of psilocybin has a lasting therapeutic effect on migraine headache, according to a new placebo-controlled study

More Accurate Clocks Unleash More Disorder in The Universe, Physicists Say